Biomimetic Innovations

Home » Affiliates » Biomimetic Innovations

Dedicated to Accelerating Medical Innovation with OsStic®

Biomimetic Innovations Ltd is a Medical Device company focused on the development and commercialisation of OsStic®, a disruptive synthetic biomaterial technology for skeletal and soft tissue repair. Born out of a decade long collaboration between PBC Biomed and GP Bio, have forged their extensive biomaterials expertise to develop a Breakthrough technology that enhances structural stability in bone. With an ISO 13485 accredited facility and offices in France (Chamonix) and United States of America (Memphis, Tennessee), Biomimetic Innovations is well positioned to accelerate medical innovation into the future

OsStic® Technology through its biomimetic mechanism of action works to enhance the natural healing process of the body and is currently being studied in both veterinary and human applications to address surgical limitations

OsStic® Benefits Clinicians & Patients

Based on extensive in-vivo studies, OsStic® offers trauma, spinal and dental clinicians and their patients, the opportunity to benefit from the disruptive attributes of this technology

Enhanced structural stability

Faster remodeling into bone

Immediate implant stabilization in poor bone quality

A biological approach to provisional fixation

Adhesive properties in a wet environment

Promoting earlier patient mobilization

OsStic® Receives FDA ‘Breakthrough Device’ Designation in 2023

OsStic® Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects to enhance structural stability where standard fixation alone cannot provide sufficient support for functional mobilization

Full Press Release